TL;DR
Get workout gear delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
A study in Nature Communications reports that imidazole propionate (ImP), a molecule made by some gut bacteria, was linked to Alzheimer’s-related biological markers and faster cognitive decline. Mouse experiments also found changes in abnormal amyloid and tau accumulation, but the human findings do not establish that ImP causes Alzheimer’s or that lowering it prevents disease.
Researchers have linked imidazole propionate (ImP), a molecule produced by some gut bacteria, with Alzheimer’s-related biological markers and faster cognitive decline in a study involving nearly 1,200 people. Mouse experiments also suggested that ImP can affect the accumulation of abnormal amyloid and tau proteins, but the findings do not establish that the molecule causes Alzheimer’s disease in people.
The study, published in Nature Communications, was led by researchers at the University of Wisconsin-Madison, including professors Barbara Bendlin and Federico Rey, with collaborators at the University of California, Los Angeles, and the University of Gothenburg. The team focused on ImP, which certain gut bacteria produce while using the amino acid histidine to generate energy. ImP production varies between people, and the bacteria that make it can be present without being abundant.
In mice, the researchers found that ImP reaching the brain increased accumulation of abnormal beta amyloid and tau, proteins associated with Alzheimer’s disease. The team also analyzed blood samples from almost 1,200 people enrolled in the Wisconsin Registry for Alzheimer’s Prevention and studies through the Wisconsin Alzheimer’s Disease Research Center. People with higher blood ImP concentrations were more likely to have biological markers associated with abnormal proteins and impaired neuron function.
Because participants had taken cognitive tests over time, researchers compared blood ImP levels with changes in thinking and memory. They reported that participants with the highest ImP levels experienced faster cognitive decline. The study also identified a genetic variation associated with higher circulating ImP; about 43% of participants carried it. The researchers suspect the variation may affect how effectively the kidneys remove ImP, but that explanation remains a hypothesis.
A Possible Gut-to-Brain Pathway
The results add a specific molecule to research into how the gut microbiome may relate to brain health. ImP can enter the bloodstream after it is produced in the gut, offering a possible route for effects beyond the digestive system. The combination of mouse findings and human associations gives researchers a target to study, but it is not evidence that changing ImP levels will prevent dementia.
The work also points to a potential treatment direction: reducing ImP in the blood rather than trying to remove a common nutrient from the diet. Histidine is an essential amino acid found in many foods, particularly protein-rich foods. Bendlin said that broadly improving diet may help health, but avoiding specific foods such as eggs or red meat is not a straightforward way to reduce ImP. The team said future treatments might instead aim to lower the molecule directly.
As an affiliate, we earn on qualifying purchases.
From Gut Microbes to ImP
The Wisconsin research team has been investigating gut microbes and Alzheimer’s for nearly a decade. Bendlin and Rey previously reported that the mix of microorganisms in the intestines differs between people with Alzheimer’s disease and healthy individuals. Their ongoing question has been how those differences might connect to changes in the brain.
ImP has also been linked in earlier research to type 2 diabetes and coronary artery disease. The new study extends investigation of the molecule to brain-related outcomes. Its findings come from both animal experiments and human data, which answer different questions: the mouse work probes possible biological effects, while the human analysis identifies associations in participants over time.
“Since then, we’ve been trying to figure out how this difference in the gut perhaps leads to changes in the brain.”
— Barbara Bendlin, University of Wisconsin-Madison professor of medicine
brain health nootropic supplements
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Cause, Risk, and Treatment Still Open
The human results show an association between higher blood ImP and Alzheimer’s-related markers and cognitive decline; they do not establish that ImP caused those outcomes. The supplied study report does not specify that lowering ImP changes disease risk or slows decline in people. The mouse results suggest a possible mechanism, but effects in mice do not by themselves establish the same effect in humans.
It is also not yet clear how the genetic variation affects ImP levels. Researchers suspect it may change kidney clearance, but the report describes this as a possibility rather than a confirmed mechanism. The study does not establish why ImP production differs among people, which groups might benefit from lowering it, or whether a safe and effective ImP-lowering treatment can be developed.
cognitive support supplements for memory
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Testing ImP-Lowering Strategies
The next research step is to test the proposed links: how the genetic variation relates to kidney removal of ImP, whether ImP directly contributes to brain changes in people, and whether lowering blood levels alters relevant outcomes. The researchers have raised the possibility of developing an inhibitor, but no such treatment or prevention benefit is established in the report.
For now, the findings are a research lead, not a basis for a specific dietary restriction or Alzheimer’s prevention plan. The study was supported in part by the Wisconsin Partnership Program, the National Institutes of Health, and the U.S. Department of Agriculture. Further studies will be needed before the molecule’s role or any clinical use can be determined.
Alzheimer's prevention supplements
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is imidazole propionate?
Imidazole propionate, or ImP, is a molecule made by certain gut bacteria as they use histidine, an amino acid. It can enter the bloodstream after it is produced in the gut.
Does the study prove ImP causes Alzheimer’s disease?
No. The human findings show an association between higher ImP and Alzheimer’s-related markers and faster cognitive decline. Mouse experiments suggested effects on amyloid and tau, but the study does not prove that ImP causes Alzheimer’s in people.
Should people avoid histidine-rich foods to lower ImP?
The researchers did not recommend avoiding foods such as eggs or red meat. Histidine is essential and occurs in many foods, and the report says dietary reduction is not a simple way to target ImP.
Could ImP lead to a new Alzheimer’s treatment?
The researchers say reducing ImP in the bloodstream could be a potential treatment target. No ImP-lowering treatment or prevention benefit has been demonstrated; further research is needed.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
